Duane C, Glavey S, Quinn J, Murphy P. Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on “Targeted anti-cancer agents and risk of venous thromboembolism”. haematol [Internet]. 2025Oct.1 [cited 2025Dec.5];110(10):2552-3. Available from: https://haematologica.org/article/view/11971